Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Pluristem Soars Most in Four Months on Results of Cell Study

Pluristem Therapeutics Inc. surged the most in more than four months after the developer of cell-therapy products said a clinical trial of its PLX-PAD cells to treat critical limb ischemia met all the protocol endpoints.

The shares jumped 11 percent the most since June 20, to 9.92 shekels at 11:41 a.m. in Tel Aviv, giving the Haifa, Israel-based company a market value of 426 million shekels ($116 million).

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.